TOP TEN perturbations for 1552954_at (Homo sapiens)
Organism: Homo sapiens
Gene: 1552954_at
Selected probe(set): 1552954_at
Platform: Affymetrix Human Genome U133 Plus 2.0 Array
Expression of 1552954_at (1552954_at) across 6673 perturbations tested by GENEVESTIGATOR:
colorectal cancer study 33 (carcinoma; colonic crypt) / normal colonic crypt epithelial cell sample
Relative Expression (log2-ratio):2.3063383Number of Samples:5 / 5
Experimental | colorectal cancer study 33 (carcinoma; colonic crypt) |
Colonic crypt epithelial cell samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma. | |
Control | normal colonic crypt epithelial cell sample |
Histopathological normal colonic crypt epithelial cells obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer. |
colorectal adenoma study 7 (colonic crypt) / normal colonic crypt epithelial cell sample
Relative Expression (log2-ratio):2.0180054Number of Samples:5 / 5
Experimental | colorectal adenoma study 7 (colonic crypt) |
Colonic crypt epithelial cell samples obtained by laser capture microdissection (LCM) from patients with colorectal adenoma. | |
Control | normal colonic crypt epithelial cell sample |
Histopathological normal colonic crypt epithelial cells obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer. |
colorectal cancer study 33 (carcinoma; colonic mucosa) / normal colon mucosa sample
Relative Expression (log2-ratio):1.8291063Number of Samples:5 / 5
Experimental | colorectal cancer study 33 (carcinoma; colonic mucosa) |
Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal carcinoma. | |
Control | normal colon mucosa sample |
Histopathological normal colon mucosa sample obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer. |
lung adenocarcinoma study 6 (K-RAS mut) / adjacent lung tissue
Relative Expression (log2-ratio):1.7546782Number of Samples:6 / 20
Experimental | lung adenocarcinoma study 6 (K-RAS mut) |
Primary tumor sample from patients with stage II adenocarcinoma carrying a K-RAS mutation. | |
Control | adjacent lung tissue |
Adjacent and histologically normal, non-tumorous lung tissue samples from patients with lung adenocarcinoma. |
lung adenocarcinoma study 6 (K-RAS mut) / lung adenocarcinoma study 6 (EGFR/K-RAS/ALK -)
Relative Expression (log2-ratio):1.6950345Number of Samples:6 / 20
Experimental | lung adenocarcinoma study 6 (K-RAS mut) |
Primary tumor sample from patients with stage II adenocarcinoma carrying a K-RAS mutation. | |
Control | lung adenocarcinoma study 6 (EGFR/K-RAS/ALK -) |
Primary tumor sample from patients with triple-negative stage II adenocarcinoma of the lung. The patients were not carrying any mutation in the EGFR, K- RAS or ALK gene. |
lung adenocarcinoma study 6 (K-RAS mut) / lung adenocarcinoma study 5 (K-RAS mut)
Relative Expression (log2-ratio):1.6629295Number of Samples:6 / 14
Experimental | lung adenocarcinoma study 6 (K-RAS mut) |
Primary tumor sample from patients with stage II adenocarcinoma carrying a K-RAS mutation. | |
Control | lung adenocarcinoma study 5 (K-RAS mut) |
Primary tumor sample from patients with stage I adenocarcinoma carrying a K-RAS mutation. |
expO kidney cancer study 1 (clear cell adenocarcinoma, NOS; metastatic) / expO kidney cancer study 1 (renal cell carcinoma, NOS; primary)
Relative Expression (log2-ratio):1.6575184Number of Samples:3 / 5
Experimental | expO kidney cancer study 1 (clear cell adenocarcinoma, NOS; metastatic) |
Metastatic tumor tissue obtained from a patient with primary clear cell adenocarcinoma (NOS) of the kidney. | |
Control | expO kidney cancer study 1 (renal cell carcinoma, NOS; primary) |
Primary tumor tissue samples obtained from the kidney of patients with renal cell carcinoma (NOS). |
colorectal adenoma study 7 (colonic mucosa) / normal colon mucosa sample
Relative Expression (log2-ratio):1.644351Number of Samples:5 / 5
Experimental | colorectal adenoma study 7 (colonic mucosa) |
Colonic mucosa samples obtained by laser capture microdissection (LCM) from patients with colorectal adenoma. | |
Control | normal colon mucosa sample |
Histopathological normal colon mucosa sample obtained by laser capture microdissection (LCM) from the distant normal colon of patients with colorectal cancer. |
HCC study 6 (primary; adrenal gland metastasis) / HCC study 6 (primary; no metastasis)
Relative Expression (log2-ratio):1.6259756Number of Samples:2 / 10
Experimental | HCC study 6 (primary; adrenal gland metastasis) |
Liver tissue sample from the primary site of patients with hepatocellular carcinoma (HCC) that metastasized to adrenal gland. | |
Control | HCC study 6 (primary; no metastasis) |
Liver tissue sample from the primary site of patients with hepatocellular carcinoma (HCC). Tumor did not metastasize. |
expO kidney cancer study 1 (clear cell adenocarcinoma, NOS; metastatic) / expO kidney cancer study 1 (clear cell adenocarcinoma, NOS; primary)
Relative Expression (log2-ratio):1.5577583Number of Samples:3 / 207
Experimental | expO kidney cancer study 1 (clear cell adenocarcinoma, NOS; metastatic) |
Metastatic tumor tissue obtained from a patient with primary clear cell adenocarcinoma (NOS) of the kidney. | |
Control | expO kidney cancer study 1 (clear cell adenocarcinoma, NOS; primary) |
Primary tumor tissue samples obtained from the kidney of patients with clear cell adenocarcinoma (NOS). |